FOXO3 and muscular atrophy: FOXO3 was also identified in a network-based analysis comparing serum proteomics in patients with Duchenne muscular dystrophy and age-matched controls28, suggesting potential for FOXO3 as a protein biomarker to monitor disease progression in conditions with severe skeletal muscle atrophy.